Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07414550 · ClinicalTrials.gov registry record · NA
Radiotherapy for Refractory Hidradenitis Suppurativa
A NA study, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07414550 is a NA study that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 10 participants.
The verdict
NCT07414550, a NA study, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if high-dose radiotherapy can provide sustained disease relief in moderate to severe, treatment resistant Hidradenitis suppurativa patients; could include any of the following: any sex/gender, and those greater then 18 years old. The main question\[s\] it aims to answer are: Outcome measure 1: Will radiotherapy change the number of inflammatory nodules, abscesses, and draining sinus tracts in the treated axilla compared with the untreated axilla? Outcome measure 2: Will radiotherapy positively change a patient's quality of life, pain levels and symptom burden? Participants will receive radiotherapy to one axilla affected by hidradenitis suppurativa. The contralateral axilla will not receive radiotherapy and will continue receiving the standard treatment regimen. Participants will... * Attend a baseline dermatology skin evaluation, complete multiple surveys and an optional participation in a biopsy * Attend multiple radiation sessions over 5 weeks * Attend 2 follow up visits with dermatology for skin evaluation, complete follow up surveys, and an optional biopsy.
Interventions
- RADIATION Radiated axilla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07414550
The ClinicalTrials.gov registry entry for NCT07414550 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiated axilla is the first listed.
NCT07414550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07414550 about?
NCT07414550 is a clinical study titled "Radiotherapy for Refractory Hidradenitis Suppurativa". The goal of this clinical trial is to learn if high-dose radiotherapy can provide sustained disease relief in moderate to severe, treatment resistant Hidradenitis suppurativa patients; could include any of the following: any sex/gender, and those greater then 18 years old. The main question\[s\] it ...
What is the current status of trial NCT07414550?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-05-01. Estimated completion is 2028-03-01.
What interventions are being tested in trial NCT07414550?
The interventions under investigation include: Radiated axilla (RADIATION).
Who is sponsoring clinical trial NCT07414550?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.